• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Millipore’s Q4, 2009 sales and earnings rise

Millipore’s Q4, 2009 sales and earnings rise

February 2, 2010 By MassDevice staff

Millipore Corp.’s (NYSE:MIL) focus on selling consumables rather than big-ticket capital equipment paid off during the fourth quarter and full year 2009, as the Billerica, Mass.-based lab instruments maker posted strong sales and earnings numbers.

Fourth-quarter net income rose 41.2 percent to $43.9 million, or 78 cents per diluted share, compared with $31.1 million, or 56 cents per diluted share, during Q4 2008. Sale for the three months ended Dec. 31, 2009, rose 7.4 percent to $426 million, compared with $396.8 million during the same period last year, despite there being six fewer business days during Q4 2009.

For the full year, Millipore posted net income of $177 million, or $3.15 per diluted share, on sales of $1.65 billion, compared with net income of $137.6 million, or $2.47 per diluted share, on sales of $1.60 million in 2008.

CFO Charles Wagner, touting the $280 million in free cash flow the company generated during the year and Millipore’s gross margin growth (up 6.4 percent for the full year, to $907 million), credited the company’s improved operations and business model for the gains.

"The exceptional cash flow performance and margin expansion we have generated over the past five years reflect substantial underlying improvements in our operations and the attractiveness of our consumables-driven business model," Wagner said in prepared remarks.

The growth came despite a significant increase in research & development spending, both during the quarter and full year. Millipore’s fourth-quarter R&D spend went from $26 million in 2008 to $30.9 million in the just-ended period, an 18.8 percent increase; for the full year, its R&D spend rose 11.7 percent to $114.6 million, compared with $102.6 million in 2008.

"We made excellent progress against our goal of accelerating product innovation through internal R&D, partnerships, and strategic acquisitions. Our R&D spending increased by 12 percent in 2009; we successfully launched a number of innovative products; we initiated collaborations with several important technology partners; and we completed four acquisitions," chairman and CEO Martin Madaus said. "All of these initiatives put us in a strong position and as we look ahead to 2010, we are confident in our ability to deliver attractive revenue growth, margin expansion, and strong cash flow."

Filed Under: Business/Financial News, Lab Instruments & Supplies, MassDevice Earnings Roundup, News Well Tagged With: Millipore Corp.

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy